Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
699 A CRISPR-Cas9 screen identifies negative regulators of CXCL9 expression by dendritic cells
- 1Department of Immunology & Department of Breast Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA
- 2Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
Related
- A genome-wide CRISPR screening identifies targets that drive tolerogenic dendritic cells
- Cross-platform multi-laboratory screening identifies HUWE1, USP33 and USP20 as negative-regulators of autophagy or mitophagy with relevance to neurodegeneration
- Dendritic cells as master regulators of the T-cell axis in sepsis: mechanisms and therapeutic implications
- CRISPR knockout screen identifies MYD88/IRAK4 signaling as a mediator of deoxynivalenol-induced oxidative damage
- Mining the Pseudomonas aeruginosa genome for regulators of type III secretion system gene expression using FT-Tn-seq
BibTeX
@article{li2026crisprcas9,
title = {{699 A CRISPR-Cas9 screen identifies negative regulators of CXCL9 expression by dendritic cells}},
author = {Jie Li and Kay Hänggi and Brian Ruffell and Achintyan Gangadharan and Olabisi Osunmakinde and Daiana Celias},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0699},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0699},
note = {CC BY},
}
RIS
TY - JOUR
TI - 699 A CRISPR-Cas9 screen identifies negative regulators of CXCL9 expression by dendritic cells
AU - Jie Li
AU - Kay Hänggi
AU - Brian Ruffell
AU - Achintyan Gangadharan
AU - Olabisi Osunmakinde
AU - Daiana Celias
PY - 2026
DA - 2026/11/07
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0699
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0699
SN - 2051-1426
ER -